Medanta Gurugram Recognized as the Best Private Hospital in India Third Time in a Row

 

World’s Best Hospitals 2022 Survey by Newsweek

 

Testimony to the world-class healthcare the hospital provides, Medanta has been ranked as the Best Private Hospital in India for the third consecutive time in a global survey conducted by Newsweek in partnership with Statista Inc. Medanta is the only private hospital in India to feature in the top 150 of the World’s Best Hospitals 2022 survey list.

Conducted across over 2,200 hospitals in 27 countries, the survey is based on recommendations from medical professionals, results from patient surveys and medical key performance indicators. This includes recommendations from over 8,00,000 medical experts (doctors, hospital managers, healthcare professionals), publicly available data from existing patient surveys and medical key performance indicators such as quality of treatment and hygiene measures.

 

“Being recognized as the best private hospital in India for three consecutive years is a testimony to the standards of clinical care delivered by our team of highly accomplished doctors and staff, world-class medical infrastructure and advanced medical technology that we offer. While the world was disrupted with COVID-19, Medanta was quick to adapt and evolve, and strived to provide full spectrum of healthcare services in a safe environment across all super specialties. We are honored to receive this recognition from a reputed and independent platform like Newsweek, and will continue furthering our commitment to making world-class healthcare accessible to all..”

 

Dr Naresh Trehan, Chairman and Managing Director, Medanta

 

Link to the survey: World’s Best Hospitals 2022 - India (newsweek.com)

 

7 Locations I Over 30 Super Specialties

• Best Clinical Expertise
• World Class Infrastructure
• Cutting-edge Technology

 

   

 

Medanta@Work

Medanta Institute of Research and Advocacy for Clean Air and Health Launched

 

 

Given the toxic levels of air pollution in Delhi-NCR, Medanta, in partnership with “Doctors for Clean Air and Climate Action”, launched Medanta Institute of Research and Advocacy for Clean Air and Health (MIRACAH). The institute’s objective is to work towards advocacy, training and research on air pollution and health. The institute aims to train Medanta employees on air pollution and health, engage with patients to highlight the importance of clean air, and conduct in-house and community-based research on air pollution and health. This is a pan-India initiative across Medanta hospitals in Gurugram, Lucknow, Patna, Indore and Ranchi, and our nationwide network of out-patient clinics.

 

The institute’s launch comes at a time when Delhi was declared as the most polluted capital according to the World Air Quality Report 2021 (prepared by Swiss organization IQAir). According to a published study by Lung Care Foundation in 2021, 29.3% of students from Delhi had spirometry defined air-flow obstruction/asthma, and around 40% of students complained of cough. Air pollution is a silent killer causing great damage to our children and impeding the future of our country. All stakeholders of society need to understand the extent of damage caused due to air pollution to our health and take steps with top priority towards cleaning the air we breathe.

 

Launching the initiative at Medanta Gurugram, Dr Naresh Trehan, Chairman and Managing Director, Medanta, said, “Air pollution is a silent killer and Medanta commits itself to do everything to achieve the goal of clean air.”

 

The launch program was organized in the presence of
Ms Jane Burston, Executive Director, Clean Air Fund, a global philanthropic initiative aimed at finding and scaling clean air solutions. “The launch of this institute is a brilliant example of the pioneering work health professionals can do in the air pollution space. Doctors can communicate scientific information in a much simpler way and networks like the ‘Doctors for Clean Air and Climate Action’ is an inspiration for doctors around the world. CAF is committed to work with organizations like Lung Care Foundation for the quality research work they produce and extensive work they do,” she said.

 

Dr Arvind Kumar, Chairman, Institute of Chest Surgery, Chest Onco-Surgery and Lung Transplantation, Medanta and Founder & Managing Trustee of Lung Care Foundation, said, “I see the impact of air pollution on the lungs of my patients every day while operating. It’s scary! As medical professionals who are aware of the damage air pollution does to our health, it is our duty to apprise the society of the health impacts of air pollution and accelerate the transition towards cleaner air through citizen and policy-level initiatives.”

 

In focus

Medanta Lucknow Launches Liver Transplant Program

 

 

With two successful transplants, Medanta has launched Liver Transplant services in Lucknow. The transplants were performed by Dr AS Soin, Chairman, Institute of Liver Transplantation and Regenerative Medicine, Medanta and his team of surgeons, Dr Amit Rastogi, Dr Prashant Bhangui, Dr Rohan Chaudhary; senior hepatologist, Dr Abhai Verma, and anesthetists, Dr Vijay Vohra and Dr CK Pandey. Padma Shri awardee, Dr AS Soin leads India’s largest and one of the world’s most successful liver transplant programs at Medanta. The liver transplant team is renowned for its 95% success rate, performing almost 20-22 transplants a month. The team has a vast experience of over 3600 liver transplants, in both paediatric and adult age groups.

 

The facility will prove beneficial for patients seeking preliminary consultation as well as opinion from super-specialists for any liver related disorders. With a world-class liver transplant centre in Lucknow, patients will not have to travel to metro cities for advanced care for end- stage liver disease.   

 

Case Studies

A 43-year-old male, suffering from alcohol related chronic liver disease for over a year, presented with severely decompensated liver cirrhosis with jaundice, ascites, spontaneous bacterial peritonitis (SBP), renal dysfunction and hepatic encephalopathy (HE). His Child-Pugh score was C and his model for end-stage liver disease (MELD) score was 20, hence, was counselled for Living Donor Liver Transplantation (LDLT).

 

While the donor was a 42-year-old male, with normal workup, the case was quite challenging. Liver volumetry revealed that the right lobe volume was 687cc with 40% remnant and Liver Attenuation Index (LAI) was +6. Liver biopsy was suggestive of normal liver. However, graft weight to recipient weight ratio (GRWR) was 0.65% which is very low. Normal GRWR should be >0.8% for successful LDLT. The recipient weighed 105 kg mainly because of fluid retention and massive ascites. He had been admitted multiple times for over two months, with two episodes of HE grade 2-3, two episodes of renal dysfunction and two episodes of spontaneous bacterial peritonitis (SBP). Throughout, he was stabilized with antibiotics, terlipressin and anti-coma measures. With a combination of multiple large volume paracentesis, fluid status optimization with albumin, diuretics and pharmacological therapy for hepatorenal syndrome, his weight was reduced to 82 kg (GRWR -0.83%) just before the transplant. The logistics of the transplant were further complicated by the fact that the donor got infected with COVID-19, and the procedure had to be delayed by three weeks following a negative RT-PCR.

 

Following his recovery from COVID-19, the donor surgery was done successfully. The seven-hour long procedure was uneventful. The graft was a modified right lobe with GRWR 0.85%, single right hepatic artery, single portal vein, reconstructed new middle hepatic vein with PTFE graft and two right hepatic ducts. The ten hour long recipient surgery was complex due to previous multiple SBPs, severe portal hypertension, and required four units of blood transfusions. Post-surgery, the recipient was shifted to ICU on ventilator and extubated the next day. During recovery, the recipient had chest infection and required non-invasive mask ventilation for respiratory distress for two days and improved on upgraded antibiotics. Donor’s post-operative course was uneventful. He was discharged on the fifth post-op day whereas the recipient was discharged on the thirteenth day following recovery. A month following the transplant, both the donor and the recipient are doing well.

 

The other case was of a terminally ill 49-year-old male who presented with liver failure which had progressed over three years despite all treatment. Hence, he was advised liver transplantation, for which his 22-year-old son donated 60% of his liver. The donor and recipient surgeries were performed successfully, and both are doing well.

 

Both donors and recipients usually regenerate their liver from half to full size within two months of transplant. In general, liver donors return to normal lives within a month, and the recipients take about a couple of months.

 

Both the cases of liver transplant, first two in Medanta Lucknow, were uneventful with optimal clinical outcomes. This is attributable to a well-coordinated effort of a highly competent team of surgeons, anesthetists, technicians and nurses supported by state-of-the-art infrastructure.

 

Dr A S Soin

Chairman
Institute of Liver Transplantation and Regenerative Medicine, Medanta

 

 

Medanta Brings World-class Chest Surgical Care to Bihar

 

In continuation of its commitment to bringing world-class, affordable healthcare to the citizens of Bihar, Medanta will now offer Chest Surgery Services in Jayprabha Medanta Hospital in Patna. Dr Arvind Kumar, Chairman, Institute of Chest Surgery, Chest Onco-Surgery and Lung Transplantation, Medanta will head the facility.

 

Dr Arvind pioneered Robotic Chest Surgery in India in 2008. A recipient of the prestigious Dr. B.C. Roy Award, Dr Arvind is globally renowned for his vast experience and exceptional success rate in surgeries for cancer of lung, thymus, food pipe and windpipe. He will be supported by his team of six dedicated chest surgeons including Dr Belal Bin Asaf, Associate Director, Dr Harsh Vardhan Puri, Consultant, Dr Sukhram Bishnoi, Associate Consultant, Dr Mohan Venkatesh Pulle, Associate Consultant, Dr Sumit Bangeria, Associate Consultant and Dr Vivek Mundale, Associate Consultant.

 

This facility will offer patients access to quality care for all chest related disorders through open, VATS/ key-hole and robotic surgeries (including benign as well as malignant chest diseases).

Dr Arvind Kumar said, “Chest diseases are on the rise.
There is need for a centre that provides comprehensive services ranging from diagnostics to post-surgical rehabilitation covering all diseases of the chest. The Institute of Chest Surgery, Chest Onco-Surgery and Lung Transplantation will fill this gap by providing treatment for chest related disorders such as Thymoma, Empyema, Chest Trauma and, Cancers of Lung, Esophagus and Trachea.”

 

 

Welcome Onboard

Dr Deeksha Kapoor, Consultant

GI Surgery, GI Oncology and Bariatric Surgery

Surgeon with expertise in GI surgery, GI oncology and complex gastrointestinal procedures. She has several publications in peer-reviewed national and international journals and is involved in multiple research projects.

 

Dr Manisha Jain, Consultant

Medical and Haemato Oncology

Haemato Oncologist with expertise in the diagnosis and treatment of benign and malignant hematological disorders like anemia, acute leukemia, lymphoma, multiple myeloma and bleeding disorders.

 

Dr Rohan Jagat Chaudhary , Consultant

Hepatobiliary and Liver Transplant Surgery

Surgeon with expertise in living donor and deceased donor liver transplantation, both in paediatric and adult age groups. He also has vast experience in complex hepatobiliary surgeries for hilar cholangiocarcinoma,
gall bladder cancer and colorectal liver metastasis.

 

Dr Narendra Singh Choudhary, Senior Consultant

Hepatology

Hepatologist with expertise in liver transplantation, endoscopic ultrasound, treatments for non-alcoholic fatty liver disease, viral hepatitis and cirrhosis.